Appeals court blocks mail-order mifepristone, restricting abortion access nationwide
Summary
A federal appeals court has temporarily stopped doctors from prescribing the abortion pill mifepristone through telehealth and mailing it to patients. The 5th U.S. Circuit Court of Appeals sided with Louisiana in a lawsuit against the FDA, blocking this method nationwide.Key Facts
- A three-judge panel from the 5th U.S. Circuit Court of Appeals made the decision.
- The ruling blocks doctors from prescribing mifepristone remotely and sending it by mail.
- The case was brought by Louisiana against the Food and Drug Administration (FDA).
- The court issued a temporary nationwide injunction, meaning the block is in effect across the whole country for now.
- Mifepristone is a pill used to end early pregnancies.
- Telehealth means patients receive medical care through video calls or online, without visiting a doctor in person.
- The FDA had allowed this method to improve abortion access, especially during the COVID-19 pandemic.
- The ruling limits this option for patients seeking abortion medication in the U.S.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.